Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Sun, Jun ^a   Zhao, Yi ^a   Hu, Jinhong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; CURCUMIN; CYTOKINE; IMIQUIMOD; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EPIDERMIS HYPERPLASIA; GAMMA DELTA T LYMPHOCYTE; GEL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; OTITIS; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION;

AMINOQUINOLINES; ANIMALS; CELL PROLIFERATION; CURCUMIN; EAR; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PSORIASIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, CCR6; RNA, MESSENGER; SKIN;

CURCUMA LONGA; MUS;

EID: 84879388555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067078     Document Type: Article

References (38)

1. Schon MP, Boehncke WH, (2005) Psoriasis. N Engl J Med 352: 1899-1912.
2. Cai Y, Shen X, Ding C, Qi C, Li K, et al. (2011) Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35: 596-610.
3. Clark RA, (2010) Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 130: 362-370.
4. Di Cesare A, Di Meglio P, Nestle FO, (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129: 1339-1350.
5. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, et al. (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 129: 79-88.
6. Shehzad A, Wahid F, Lee YS, (2010) Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim) 343: 489-499.
7. Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, et al. (2002) Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95: 1206-1214.
8. Cho JW, Lee KS, Kim CW, (2007) Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 19: 469-474.
9. Hussain AR, Ahmed M, Al-Jomah NA, Khan AS, Manogaran P, et al. (2008) Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther 7: 3318-3329.
10. Sugimoto K, Hanai H, Tozawa K, Aoshi T, Uchijima M, et al. (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123: 1912-1922.
11. Camacho-Barquero L, Villegas I, Sanchez-Calvo JM, Talero E, Sanchez-Fidalgo S, et al. (2007) Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 7: 333-342.
12. Bharti AC, Donato N, Aggarwal BB, (2003) Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171: 3863-3871.
13. Saydmohammed M, Joseph D, Syed V, (2010) Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells. J Cell Biochem 110: 447-456.
14. Natarajan C, Bright JJ, (2002) Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168: 6506-6513.
15. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, et al. (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182: 5836-5845.
16. Patel NA, Patel NJ, Patel RP, (2009) Formulation and evaluation of curcumin gel for topical application. Pharm Dev Technol 14: 80-89.
17. Mahaisavariya P, Jiamton S, Manonukul J, Khemngern S, (2000) Mast cells in leprosy and leprosy reaction. Int J Dermatol 39: 274-277.
18. Farahani SS, Navabazam A, Ashkevari FS, (2010) Comparison of mast cells count in oral reactive lesions. Pathol Res Pract 206: 151-155.
19. Leverkus M, Yaar M, Gilchrest BA, (1997) Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 232: 255-262.
20. Beutner KR, Tyring S, (1997) Human papillomavirus and human disease. Am J Med 102: 9-15.
21. Szeimies RM, Gerritsen MJ, Gupta G, Ortonne JP, Serresi S, et al. (2004) Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 51: 547-555.
22. Geisse JK, Rich P, Pandya A, Gross K, Andres K, et al. (2002) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 47: 390-398.
23. Palamara F, Meindl S, Holcmann M, Luhrs P, Stingl G, et al. (2004) Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J Immunol 173: 3051-3061.
24. Fujisawa H, Shivji GM, Kondo S, Wang B, Tomai MA, et al. (1996) Effect of a novel topical immunomodulator, S-28463, on keratinocyte cytokine gene expression and production. J Interferon Cytokine Res 16: 555-559.
25. Kono T, Kondo S, Pastore S, Shivji GM, Tomai MA, et al. (1994) Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression. Lymphokine Cytokine Res 13: 71-76.
26. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, et al. (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122: 201-206.
27. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80: 273-290.
28. Dinarello CA, (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519-550.
29. Tsuruta D, (2009) NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov 3: 40-48.
30. Moseley TA, Haudenschild DR, Rose L, Reddi AH, (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14: 155-174.
31. Aggarwal S, Gurney AL, (2002) IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 71: 1-8.
32. Kolls JK, Linden A, (2004) Interleukin-17 family members and inflammation. Immunity 21: 467-476.
33. Schwandner R, Yamaguchi K, Cao Z, (2000) Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 191: 1233-1240.
34. Ivanov, II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
35. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, et al. (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11: 43-49.
36. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, et al. (2006) IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36: 1309-1323.
37. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL, (2008) gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20: 353-357.
38. Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A, (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130: 1373-1383.